KCM
BHVN

Knoll Capital Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$12.6M Buy
895,269
+64,390
+8% +$909K 8.98% 2
2025
Q1
$20M Buy
830,879
+70,457
+9% +$1.69M 12.99% 2
2024
Q4
$28.4M Buy
760,422
+50,000
+7% +$1.87M 18.28% 1
2024
Q3
$35.5M Hold
710,422
16.45% 2
2024
Q2
$24.7M Buy
710,422
+220,000
+45% +$7.64M 16.62% 2
2024
Q1
$26.8M Hold
490,422
16.69% 2
2023
Q4
$21M Hold
490,422
17.38% 1
2023
Q3
$12.8M Buy
490,422
+40,000
+9% +$1.04M 13.24% 3
2023
Q2
$10.8M Hold
450,422
13.06% 2
2023
Q1
$6.15M Hold
450,422
9.48% 2
2022
Q4
$6.25M Sell
450,422
-450,422
-50% -$6.25M 14.11% 2
2022
Q3
$136M Hold
900,844
79.57% 1
2022
Q2
$131M Hold
900,844
75% 1
2022
Q1
$107M Buy
900,844
+4,000
+0.4% +$474K 67.04% 1
2021
Q4
$124M Buy
896,844
+40,000
+5% +$5.51M 67.92% 1
2021
Q3
$119M Hold
856,844
59.36% 1
2021
Q2
$83.2M Hold
856,844
43.44% 1
2021
Q1
$58.6M Sell
856,844
-650
-0.1% -$44.4K 38.16% 1
2020
Q4
$73.5M Hold
857,494
50.11% 1
2020
Q3
$55.7M Hold
857,494
45.68% 1
2020
Q2
$62.1M Hold
857,494
35.84% 1
2020
Q1
$29.2M Hold
857,494
27.41% 1
2019
Q4
$46.6M Hold
857,494
34.43% 1
2019
Q3
$35.8M Buy
857,494
+107,679
+14% +$4.49M 32.74% 1
2019
Q2
$32.8M Hold
749,815
26.88% 2
2019
Q1
$38.6M Hold
749,815
29.33% 1
2018
Q4
$27.7M Hold
749,815
31.54% 1
2018
Q3
$27.9M Hold
749,815
23.6% 3
2018
Q2
$29.6M Hold
749,815
25.18% 2
2018
Q1
$19.3M Sell
749,815
-57,409
-7% -$1.48M 19.83% 3
2017
Q4
$21.8M Hold
807,224
19.2% 3
2017
Q3
$30.2M Hold
807,224
25.78% 2
2017
Q2
$20.2M Buy
+807,224
New +$20.2M 26.75% 2